Schwartz Matthew C, Sullivan Lisa M, Glatz Andrew C, Rand Elizabeth, Russo Pierre, Goldberg David J, Rome Jonathan J, Cohen Meryl S
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Pediatr Cardiol. 2013 Jan;34(1):135-42. doi: 10.1007/s00246-012-0402-9. Epub 2012 Jun 14.
Hepatic fibrosis is an important complication after Fontan surgery in patients with single-ventricle congenital heart disease. Few reports of hepatic histology in these patients exist, and sinusoidal fibrosis has been described. We aimed to characterize fibrosis at liver biopsy procedure in patients with previous Fontan surgery and to identify patient variables associated with the degree of fibrosis. All patients who had previous Fontan surgery and who subsequently underwent liver biopsy at our institution between January 1990 and July 2010 were identified. For each biopsy specimen, portal and sinusoidal fibrosis were graded and medical records reviewed. Biopsy specimens from 13 patients were examined; the median time from Fontan surgery to liver biopsy procedure was 16.9 years (range 6.9-25). At the most recent biopsy procedure, 12 patients (92 %) had evidence of portal fibrosis, including 1 patient with portal-based cirrhosis. Thirteen patients (100 %) had at least some degree of sinusoidal fibrosis, including 1 patient with centrilobular-based cirrhosis. Lower platelet count was associated with greater degree of portal fibrosis by ordinal regression (odds ratio 0.84, P = 0.04), and patients with no or mild portal fibrosis had significantly higher platelet counts compared with those with moderate or severe portal disease (278 ± 78 K vs. 160 ± 46 K, P = 0.005). Four patients underwent serial biopsy procedures; portal fibrosis was progressed in 3 patients, and sinusoidal fibrosis was progressed in 3 patients. After Fontan surgery, portal and sinusoidal fibrosis are common at liver biopsy and can progress over time. Lower platelet count may represent a marker of portal-based disease in these patients.
肝纤维化是单心室先天性心脏病患者接受Fontan手术后的一种重要并发症。关于这些患者肝脏组织学的报道很少,且已有关于窦性纤维化的描述。我们旨在对接受过Fontan手术的患者在肝活检时的纤维化特征进行描述,并确定与纤维化程度相关的患者变量。我们确定了1990年1月至2010年7月期间在我们机构接受过Fontan手术且随后接受肝活检的所有患者。对每个活检标本的门静脉和窦性纤维化进行分级,并查阅病历。检查了13例患者的活检标本;从Fontan手术到肝活检的中位时间为16.9年(范围6.9 - 25年)。在最近一次活检时,12例患者(92%)有门静脉纤维化证据,其中1例为门静脉性肝硬化。13例患者(100%)至少有一定程度的窦性纤维化,其中1例为小叶中心性肝硬化。通过有序回归分析,较低的血小板计数与门静脉纤维化程度加重相关(优势比0.84,P = 0.04),与中度或重度门静脉疾病患者相比,无或轻度门静脉纤维化患者的血小板计数显著更高(278 ± 78 K对160 ± 46 K,P = 0.005)。4例患者接受了系列活检;3例患者门静脉纤维化进展,3例患者窦性纤维化进展。Fontan手术后,门静脉和窦性纤维化在肝活检中很常见,且可随时间进展。较低的血小板计数可能是这些患者门静脉疾病的一个标志。